Madam Speaker, I do not know if the member for Louis-Saint-Laurent knows people at the U.S. Food and Drug Administration, but I do not think it is responsible to speculate about what another country's regulatory body will do.
As we have been saying for a long time, we are in this with our allies, Australia, New Zealand, the United Kingdom and the European Union. We have a very substantial and comprehensive portfolio of vaccines, and we can assure Canadians that the vaccines will be available when Canada is ready, when—